I recently had the opportunity to conduct an interview with Andrei Iancu, Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office, via WebEx. The focus of our conversation was the COVID-19 pandemic: USPTO efforts to work with stakeholders, the role of intellectual property in finding cures and treatments, and general thoughts relating to what the Office is observing. Our conversation also veered into Bayh-Dole and the the letter just sent by three-dozen state Attorneys General asking the federal government to use march-in rights against Remdesivir.
A Conversation with Andrei Iancu on the Role of Innovation and the USPTO in Combating COVID-19
No Comments
Patent
- Enablement
- Fee Shifting
- Litigation
- NetSoc Appeals to SCOTUS, Claiming Improper Analysis of Social Network Patent Nixed Under 101
- The View from the Court’s 2 Live Crew: Examining the Thomas/Alito Dissent in Google v. Oracle
- Tillis, Michel and Iancu Back Ericsson in Heated International FRAND Dispute with Samsung
- The mRNA IP and Competitive Landscape Through One Year of the COVID-19 Pandemic – Part I
- The Upshot of Google v. Oracle: An Absurd Ruling Will Lead to Absurd Results
Recent Posts
- NetSoc Appeals to SCOTUS, Claiming Improper Analysis of Social Network Patent Nixed Under 101
- The View from the Court’s 2 Live Crew: Examining the Thomas/Alito Dissent in Google v. Oracle
- Tillis, Michel and Iancu Back Ericsson in Heated International FRAND Dispute with Samsung
- The mRNA IP and Competitive Landscape Through One Year of the COVID-19 Pandemic – Part I
- The Upshot of Google v. Oracle: An Absurd Ruling Will Lead to Absurd Results